Loading...
PhD Tanja Jesenko

PhD Tanja Jesenko
no.: 33227 source: ARIS

researcher – active in research organisation
E-mail tjesenkoat signonko-i.si
Research activity

Code Science Field Subfield
3.04.00  Medical sciences  Oncology   
Bibliography Representative bibliographic units | Personal| COBISS+
source: COBISS
source: SICRIS
Points
346.51
A''
0
A'
182.96
A1/2
230.21
CI10
458
CImax
53
h10
12
A1
1.19
A3
4.62
Data for the last 5 years (citations for the last 10 years) on June 13, 2024; A3 for period 2018-2022 (update for tender in 2023: YES)
Data for ARIS tenders ( 21.05.2024 – Target research programmes, archive )
Database Linked records Citations Pure citations Average pure citations
WoS 46  597  373  8.11 
Scopus 41  702  457  11.15 
Mentoring junior researchers
source: ARIS
no. Name and surname Type Period Code
1 Živa Pišljar  Bologna doctoral studies  10/1/2020 - 9/30/2024  54718 
Education
source: ARIS
Level of education Professional title Study subject Faculty Year
      SI Univeristy of Ljubljana, Faculty of Chemistry and Chemical Technology 2010 
Doctor's degree  Ph. D.   Biomedicine  SI University of Ljubljana, Faculty of Medicine 2014 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group Date of employment Position Role Title
Full time employment (100%, RD:100%)  Institute of Oncology Ljubljana  Department of research  11/1/2010    Researcher   
Research projects Legend
source: ARIS
no. Code Title Period Head No. of publications
1. J3-50108  DEBIO 1143 has a potential to increase effectiveness of electrochemotherapy and radiotherapy in HPV positive and HPV negative Head and Neck Cancers   2023 - 2024  PhD Katarina Žnidar  2,208 
2. J4-50150  Erythrocyte membrane-based nanocarriers for gene silencing cancer therapy   2023 - 2024  PhD Nina Kostevšek  3,930 
3. L3-50111  Gene immuno-therapy of solid tumors based on mRNA encoding interleukin-12: So-rIL   2023 - 2024  PhD Maja Čemažar  2,849 
4. J3-50110  Intratumoral mRNA electrotransfer: establishment and preclinical proof of concept   2023 - 2024  PhD Katja Uršič Valentinuzzi  3,112 
5. J2-50068  Safety and efficacy of high frequency electrochemotherapy - clinical device development   2023 - 2024  PhD Matej Reberšek  3,487 
6. L7-4491  Development of integrated multi-channel artificial nose for detection of cancer   2022 - 2024  PhD Igor Muševič  5,502 
7. J7-4635  MitoCan - Preclinical development of new Mitochondrial ion channel inhibitors for Cancer therapy   2022 - 2024  PhD Lucija Peterlin Mašič  6,100 
8. J3-3083  Vascularization and vascular effects as predictive factors for local ablative techniques   2021 - 2024  PhD Gregor Serša  6,811 
9. J3-2528  Immuno gene electrotransfer of IL-12 and IL-2 in immunologically cold/hot tumors   2020 - 2022  PhD Maja Čemažar  3,193 
10. J3-2529  Role of endothelium in tumor response to radiotherapy   2020 - 2022  PhD Boštjan Markelc  3,460 
11. J7-2594  The amniotic membrane as a novel multimodal therapy for bacterial cystitis and bladder cancer: unravelling its antimicrobial, immunomodulatory and anticancer activity   2020 - 2022  PhD Mateja Erdani Kreft  5,226 
12. Z3-8204  Involvement of cytosolic DNA sensors in irradiation induced bystander and abscopal effect   2018 - 2020  PhD Tanja Jesenko  170 
13. J1-6730  Development of new hepatic cell lines for genotoxicity and carcinogenicity studies: new hope for human health and laboratory animal welfare protection   2014 - 2017  PhD Metka Filipič  4,071 
14. J3-6793  New approaches of tumor radiosenzibilization with gene therapy   2014 - 2017  PhD Gregor Serša  5,119 
15. J3-6796  Translational oncology: development and validtion of immunogene therapy with Interleukin-12 combined with surgery for canine cancers of the oral cavity and skin   2014 - 2017  PhD Maja Čemažar  4,772 
16. J3-5505  Electrochemotherapy in treatment of deep seated tumors   2013 - 2016  PhD Gregor Serša  4,292 
17. L2-4105  Development and validation of a software for numerical modeling of in vivo electroporation - in silico electroporation   2011 - 2014  PhD Damijan Miklavčič  4,843 
18. J3-4259  Preparation and validation of therapeutic plasmids without selection gene for antibiotic resistance for cancer gene therapy using inducible and tissue-specific promoters   2011 - 2014  PhD Maja Čemažar  5,890 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head No. of publications
1. P3-0003  Development and evaluation of new approaches to cancer treatment   2022 - 2024  PhD Gregor Serša  3,971 
2. P3-0003  Development and evaluation of new approaches to cancer treatment   2015 - 2021  PhD Gregor Serša  3,283 
3. P3-0003  Development and evaluation of new approaches to cancer treatment   2010 - 2014  PhD Gregor Serša  4,042 
Views history
Favourite